Live Attenuated Influenza Vaccines engineered to express the nucleoprotein of a recent isolate stimulate human influenza CD8+ T cells more relevant to current infections

Hum Vaccin Immunother. 2018 Apr 3;14(4):941-946. doi: 10.1080/21645515.2017.1417713. Epub 2018 Jan 23.

Abstract

Live attenuated influenza vaccines (LAIV) induce CD8+ T lymphocyte responses that play an important role in killing virus-infected cells. Despite the relative conservation of internal influenza A proteins, the epitopes recognized by T cells can undergo drift under immune pressure. The internal proteins of Russian LAIVs are derived from the master donor virus A/Leningrad/134/17/57 (Len/17) isolated 60 years ago and as such, some CD8+ T cell epitopes may vary between the vaccine and circulating wild-type strains. To partially overcome this issue, the nucleoprotein (NP) gene of wild-type virus can be incorporated into LAIV reassortant virus, along with the HA and NA genes. The present study compares the human CD8+ T cell memory responses to H3N2 LAIVs with the Len/17 or the wild-type NP using an in vitro model.

Keywords: Antigenic escape; LAIV; T cell epitope; influenza; nucleoprotein.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Viral / immunology
  • CD8-Positive T-Lymphocytes / immunology*
  • Cell Line, Tumor
  • Epitopes, T-Lymphocyte / immunology
  • Humans
  • Influenza A Virus, H3N2 Subtype / immunology
  • Influenza Vaccines / immunology*
  • Influenza, Human / immunology*
  • Influenza, Human / prevention & control*
  • Nucleoproteins / immunology*
  • Russia
  • Vaccines, Attenuated / immunology*

Substances

  • Antibodies, Viral
  • Epitopes, T-Lymphocyte
  • Influenza Vaccines
  • Nucleoproteins
  • Vaccines, Attenuated

Grants and funding

The study was supported by Russian Science Foundation Grant №14–15–00034.